Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup S. Pathania, Philip Prathipati, Abdul Bakrudeen Ali Ahmed, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 731-753
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond
Yuanfeng Zhu, Xiaoli Chen, Xin Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 129
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
Noha Sharafeldin, Benjamin Bates, Qianqian Song, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 20, pp. 2232-2246
Open Access | Times Cited: 119
Association of COVID-19 with Comorbidities: An Update
Sayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 3, pp. 334-354
Open Access | Times Cited: 53
Predicting the hub interactome of COVID-19 and oral squamous cell carcinoma: uncovering ALDH-mediated Wnt/β-catenin pathway activation via salivary inflammatory proteins
Pradeep Kumar Yadalam, Deepavalli Arumuganainar, Prabhu Manickam Natarajan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care
Alena Mazuráková, Lenka Koklesová, Marek Samec, et al.
The EPMA Journal (2022) Vol. 13, Iss. 2, pp. 315-334
Open Access | Times Cited: 52
New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19
Ting Li, Jiewen Fu, Jingliang Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Bidirectional approach of Punica granatum natural compounds: reduction in lung cancer and SARS-CoV-2 propagation
Md. Abul Barkat, Afreen Fatima, Bushra Riaz, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
Impact of the COVID-19 Pandemic on the Treatment of Head and Neck Cancers
Max Lee, Andrey Finegersh, Michelle Chen
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1424-1424
Open Access
Bioinformatics and System Biology Approach to Identify the Influences of COVID-19 on Rheumatoid Arthritis
Huan Hu, Nana Tang, Facai Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV
Cheng Yan, Yandie Niu, Xuannian Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
Sally A. Fahim, Yehia A. ElZohairy, Rehab I. Moustafa
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Effect of anti-COVID-19 drugs on patients with cancer
Weicai Huang, Wenyu Liu, Tingting Yu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116214-116214
Open Access | Times Cited: 3
Risk of Early Postoperative Cardiovascular and Cerebrovascular Complication in Patients with Preoperative COVID-19 Undergoing Cancer Surgery
Gopika SenthilKumar, Nathaniel B. Verhagen, Kaitlyn Nimmer, et al.
Journal of the American College of Surgeons (2024) Vol. 238, Iss. 6, pp. 1085-1097
Closed Access | Times Cited: 3
War or peace: Viruses and metastasis
Mobina Bayat, Shahin Golestani, Saeed Motlaghzadeh, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189179-189179
Closed Access | Times Cited: 3
The Impact of COVID-19 on Cancer
Yue Li, Xingjian Wang, Wei Wang
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 3809-3816
Open Access | Times Cited: 22
The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants
Qing Wu, Shuimei Luo, Xianhe Xie
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection
Víctor Urbiola-Salvador, Suiane Lima de Souza, Peter Grešner, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6276-6276
Open Access | Times Cited: 8
Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
Aditi D. Kunvariya, Shivani A. Dave, Zeal J. Modi, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15644-e15644
Open Access | Times Cited: 8
COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
Simon Moubarak, Diala Merheb, Lynn Basbous, et al.
Journal of International Medical Research (2022) Vol. 50, Iss. 9
Open Access | Times Cited: 13
Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
Na Qu, Zongguang Hui, Zhixin Shen, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 12
The multifaceted antineoplastic role of pyrimethamine against human malignancies
Shanaya Ramchandani, Chakrabhavi Dhananjaya Mohan, Jenaifer Rustom Mistry, et al.
IUBMB Life (2021) Vol. 74, Iss. 3, pp. 198-212
Closed Access | Times Cited: 13
Bioinformatics and system biology approach to identify the influences among COVID-19, influenza, and HIV on the regulation of gene expression
Zhen Zhang, Hao Jin, Xu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
Trends analysis of cancer incidence, mortality, and survival for the elderly in the United States, 1975–2020
Jia Xu, Jingyuan Liao, Qiong Yan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 1
Risk of COVID-19 infection in patients with NSCLC receiving EGFR-TKI targeted therapy during the first wave in China
Peng Huang, Ling-Ming Liao, Jiali Zhao, et al.
Journal of International Medical Research (2024) Vol. 52, Iss. 10
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top